Ubs Group Ag Molecular Partners Ag Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Molecular Partners Ag stock. As of the latest transaction made, Ubs Group Ag holds 6,872 shares of MOLN stock, worth $34,566. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,872
Previous 5,246
31.0%
Holding current value
$34,566
Previous $26,000
23.08%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding MOLN
# of Institutions
6Shares Held
3.58MCall Options Held
0Put Options Held
0-
Suvretta Capital Management, LLC New York, NY2.22MShares$11.2 Million0.44% of portfolio
-
Bvf Inc San Francisco, CA1.35MShares$6.81 Million0.24% of portfolio
-
Morgan Stanley New York, NY367Shares$1,8460.0% of portfolio
-
Rhumbline Advisers Boston, MA269Shares$1,3530.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About MOLECULAR PARTNERS AG
- Ticker MOLN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,514,000
- Market Cap $164M
- Description
- Molecular Partners AG operates as a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic proteins. Its products candidates include Abicipar, a DARPin therapeutic candidate, which is in Phase III clinical trials for the treatment of neovascular wet age-related macular degeneration, ...